A direct comparison of Positron Emission Tomography (PET) (11C-Raclopride) and Single Photon Emission Computed Tomography (SPECT) (123I-IBZM) D2 RO measurements would allow GSK to gain understanding on the SPECT results obtained with SB773812, and to accurately interpret future D2 RO results from either PET or SPECT studies with new compounds.
Study Type
OBSERVATIONAL
Enrollment
60
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Barcelona, Spain
PET and SPECT striatal binding potential
Time frame: at day 1
plasma concentrations at the time of scanning,
Time frame: at day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Espluges de Llobregat, Spain
GSK Investigational Site
Sant Boi de Llobregat, Spain